Related Experiment Videos
Multiple myeloma presenting as primary non-secretory plasma cell leukemia
Jitender Mohan Khunger1, Mukesh Sharma, V H Talib
1Department of Haematology,VMMC & Safdarjang Hospital, New Delhi. jitenderkhunger@hotmail.com
Indian Journal of Pathology & Microbiology
|March 19, 2004
Summary
Primary plasma cell leukemia, a rare multiple myeloma variant, involves mature B cells. Diagnosis requires over 2 billion plasma cells/liter blood or 20% of leukocytes being plasma cells.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Primary plasma cell leukemia (PCL) is a rare and aggressive variant of multiple myeloma.
- The exact neoplastic hierarchy and classification of PCL within malignant hematological disorders remain incompletely understood.
- Morphological and immunological studies suggest PCL cells represent the terminal stage of B-cell maturation.
Observation:
- This case report details a young male patient diagnosed with primary plasma cell leukemia.
- The diagnosis was established based on the presence of over 2 x 10^9 plasma cells per liter of peripheral blood.
- Alternatively, diagnosis is confirmed if plasma cells constitute more than 20% of leukocytes in a differential count.
Findings:
- Primary plasma cell leukemia can arise de novo or as an advanced stage in patients with pre-existing multiple myeloma.
- The study highlights the diagnostic criteria for this uncommon hematological malignancy.
- The presented case underscores the clinical presentation of PCL in a young male demographic.
Implications:
- Further research is needed to clarify the precise classification and hierarchy of PCL in hematological malignancies.
- Understanding the B-cell maturation pathway is crucial for developing targeted therapies for PCL.
- This case report contributes to the limited literature on primary plasma cell leukemia, particularly in younger patients.